Discussing worldwide pathological myopia

By Caroline Richards
Ramin Tadayoni, MD, PhD
Conference|EURETINA

Dr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.

Additional EURETINA coverage

Related Videos
View All
Related Content

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Risk of rhegmatogenous retinal detachment rises following cataract surgery

October 4th 2022

What to expect from virtual AAO 2020

November 5th 2020

Fewer ocular symptoms linked to e-cigarettes than traditional cigarettes

October 3rd 2022

Faricimab for nAMD: Safe, effective, lower treatment burden compared with aflibercept in pooled TENAYA, LUCERNE Phase 3 trials

October 2nd 2022

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Risk of rhegmatogenous retinal detachment rises following cataract surgery

October 4th 2022

What to expect from virtual AAO 2020

November 5th 2020

Fewer ocular symptoms linked to e-cigarettes than traditional cigarettes

October 3rd 2022

Faricimab for nAMD: Safe, effective, lower treatment burden compared with aflibercept in pooled TENAYA, LUCERNE Phase 3 trials

October 2nd 2022

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Risk of rhegmatogenous retinal detachment rises following cataract surgery

October 4th 2022

What to expect from virtual AAO 2020

November 5th 2020

Fewer ocular symptoms linked to e-cigarettes than traditional cigarettes

October 3rd 2022

Faricimab for nAMD: Safe, effective, lower treatment burden compared with aflibercept in pooled TENAYA, LUCERNE Phase 3 trials

October 2nd 2022
Advertise
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.